Distributions of CA, SCE and MU in a Human Population some of them, cigarette smoking status and sex for SCE, for example, and have reason to suspect others, such as age for both CA and SCE. But there are doubtless others, including, perhaps most importantly, genetic factors.
Frequencies of chromosomal aberrations
Some years ago, Bender, Preston, and collaborators undertook, with support from the U.S. National Toxicology Program (NTP), a study aimed at determining something about measured variances of "spontaneous" CA and SCE frequencies in peripheral blood lymphocytes from a stratified random sample of normal, healthy persons. The population from which it was drawn was the Brookhaven National Laboratory (BLN) workforce. Stratification of the random sample was done to assure a reasonably balanced sex and racial representation; the workforce is largely male and white. We extended the age range represented by including BLN retirees on the one hand and by drawing subjects from among patrons of a local paediatric unit on the other. Ultimately, we sampled almost 500 subjects aged one to eighty-four years, many of them several times, in order to estimate intra-individual variance (Bender et al. 1988; 1989) . We were able to confirm the earlier-reported large influence of cigarette smoking and the smaller influence of sex on SCE frequencies, but did not see the influence of age on either SCE or CA frequencies reported by some authors, with the single exception of the dicentric chromosome, for which our data showed a strong positive regression on age. We studied the distributions of both SCE and CA among cells and of SCE and CA means among subjects both to assess the propriety of the usual statistical tests for differences between means and as a way of assessing the possibility that different subjects might have different intrinsic means (Bender et al. 1990; 1992a) .
In addition, more recently, we decided it would be worthwhile to set up a similar study which would measure means and variances for responses to deliberate in vitro mutagen challenges as well as, of course, "spontaneous" levels. We reasoned that if there are large DNA enzymatic repair deficiences of genetic origin in the human population, like xeroderma pigmentosum (XP), ataxia telangiectasia (AT) and Fanconi anemia (FA), then there might well be smaller differences in DNA repair capacity among normal, healthy people. This, if true, could have important implications for carcinogen/mutagen hazard evaluation and standards setting. We set up a project to evaluate this possibility, again using peripheral lymphocyte samples from volunteers from the BLN workforce. Because of our somewhat different objectives, our sampling is not as rigidly random as was that for the earlier study.
We selected a battery of four different mutagen/carcinogens, selected to "exercise" four different, known types of enzymatic DNA repair. We selected both fairly direct DNA repair capacity measurements and biological endpoints.
